Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Visit http://indiaer.blogspot.com/ for complete details �� ��
Cadila Healthcare
|
Slowing business momentum - Maintain Hold
|
HOLD
CMP: Rs 760 Target Price: Rs 760
n Muted revenue growth (up 11% YoY) to Rs12.4bn and poor operating performance (up 6% YoY) to Rs2bn resulted in 2% YoY de-growth in Adjusted PAT to Rs1.77bn
n Muted revenue growth was due to 7% growth in domestic formulations, 5% growth in Consumer business and 5% in Europe business
n Higher interest expenses because of increase in debt by ~Rs10bn to Rs20bn over the last 6 months. Company is looking for strategic investment in US
n With business momentum slowing down and possibility of earnings downgrade going forward– we maintain Hold rating with a revised target price of Rs760 (17xFY13 EPS of Rs44.7)
No comments:
Post a Comment